BAY2586116 Nasal Spray and OSA Severity

NCT05527457 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Sleep Apnea, Obstructive

Interventions

DRUG: BAY2586116
DRUG: Placebo

Sponsor

Flinders University

Collaborators

[object Object]